In Texas, Aprima Medical Software is integrating the ActX Genomic Decision Support platform into its electronic health records and should have it available later this summer. Used by medical practices, Aprima’s software will now allow clinics and doctors to access patient genomics information from their offices to improve personalized patient care, including prescription drug interaction alerts based on patients’ genetic profiles. Andrew Ury M.D., ActX CEO, told PR Newswire, “We are proud to help Aprima make genomics a practical part of everyday medical care by building genomic decision support into their normal physician workflow.” By having this genetic information available in the medical office, doctors can ensure they have considered hereditary risks and genomic profiles before prescribing medications or other treatments.
Latest article
Body-based burial: Students imagine urns made from blood and hair
In Slovenia, students at University of Ljubljana have used biobased materials for a variety of design projects, including a biodegradable urn made of blood...
Uttar Pradesh eyes cow poop plastics to boost rural economy
In Uttar Pradesh, a government project is collecting cow dung to convert into usable products such as bioplastics, textiles, and paper.
The Press Trust...
Luxury brand Velvet Eyewear lauds advances in biobased acetate
In California, luxury women’s eyewear brand Velvet Eyewear has unveiled its first biobased eyewear collection.
Crafted from renewable sources like wood pulp and cotton...